Shilpa Gupta, Professor of Medicine at CLeveland Clinic, shared Brian Rini’s post on X, adding:
“Bravo Brian Rini on this tremendous work to pioneer biomarker-driven approaches to Tx selection in RCC!
The future of personalized therapy in kidney cancer is looking bright!”
Brian Rini, Professor at Vanderbilt University Medical Center, shared:
“Several groups have attempted to predict the IM151 RCC clusters with flawed methods.
We developed IRIS-RCC (Individual RNA-seq Intrinsic Subtyping for RCC; available at https://irisrcc.vindhyadatascience.com), to predict clusters using an individual-sample model.”
Title: An individual sample predictive model to classify patients with metastatic renal cell carcinoma
Authors: Anupama Reddy, W. Jared Brewer, Scott M. Haake, Brian Rini
You can also read:
LITESPARK-011 at ESMO 2026: Association Between HRQoL and Clinical Outcomes in Advanced RCC
